or Try an Advanced Search...

    ETF Components for KNGS - Roundhill S&P Dividend Monarchs ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    KVUE A 0.00 5.66
    BKH A 0.00 4.94
    FRT B 0.00 4.55
    SWK F 0.00 4.45
    SON D 0.00 4.28
    ABBV F 0.00 4.26
    NFG A 0.00 4.10
    HRL D 0.00 3.66
    JNJ D 0.00 3.54
    KMB C 0.00 3.44

    Represented by ETF Holdings

    Keywords: S&P 500 Infection Gas Transportation Infection Prevention Infection Prevention Products Johnson & Johnson Natural Gas Pain Pain Management Plastic Retail Outlets Self Care Skin Care Adalimumab Advanced Prostate Cancer Aerospace Allergy Anemia Antipsychotic Atopic Dermatitis
    Industries: Drug Manufacturers - Major Household & Personal Products Oil & Gas E&P Packaged Foods Packaging & Containers REIT - Retail Tools & Accessories Utilities - Diversified

    Recent News for Roundhill S&P Dividend Monarchs ETF & its Holdings

    Date Stock Title
    Nov 20 SWK Stanley Black & Decker CEO on potential Trump tariffs: Tool prices will go up
    Nov 20 SWK Tariffs can be good for 'certain industries': Stanley Black & Decker CEO
    Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
    Nov 20 KNGS Target plunge: 5 ETFs holding the retailer as its shares slide on profit worries
    Nov 20 SWK Stanley Black & Decker Provides Strategic Update at Capital Markets Day
    Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
    Nov 20 HRL How Genuine Parts, Hormel Foods And Hershey Can Put Cash In Your Pocket
    Nov 20 SWK Here's Why You Should Retain Stanley Black Stock in Your Portfolio for Now
    Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
    Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
    Nov 19 ABBV Where Will AbbVie Be in 5 Years?
    Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
    Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
    Nov 19 JNJ J&J pill clears skin in two late-stage psoriasis studies
    Nov 19 JNJ Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
    Nov 19 ABBV RVPH: Year-End OLE Update
    Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
    Nov 18 ABBV AbbVie snaps eight straight sessions of losses
    Nov 18 JNJ J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis
    Nov 18 JNJ Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
    The fund generally invests in securities that Upholdings believes have the potential to compound at a higher rate than the S&P 500 Index over multi-year periods. It will invest at least 60% of its total net assets in equity securities of companies of medium and large market capitalizations located in both the United States. The fund will also invest in other international markets, including emerging markets. It is non-diversified.
    Index Fund Stock Fund Financial Market
    Back to the Main KNGS Page...